Precision post-translational modification of PML defines neuroblastoma clinical behaviour.

Mohanvelu S, Subramanian P, Aravindan S, Ramamurthy MO, Aravindan S, Jahir Hussain AP, Aravindan N.

Open source

DOI
10.1002/ctm2.70763
Published
2026-08-01
Container
Clin Transl Med
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70763,
  title = {Precision post-translational modification of PML defines neuroblastoma clinical behaviour.},
  author = {Mohanvelu S and  Subramanian P and  Aravindan S and  Ramamurthy MO and  Aravindan S and  Jahir Hussain AP and  Aravindan N.},
  year = {2026},
  journal = {Clin Transl Med},
  doi = {10.1002/ctm2.70763},
  url = {https://doi.org/10.1002/ctm2.70763}
}

RIS

TY  - JOUR
TI  - Precision post-translational modification of PML defines neuroblastoma clinical behaviour.
AU  - Mohanvelu S
AU  -  Subramanian P
AU  -  Aravindan S
AU  -  Ramamurthy MO
AU  -  Aravindan S
AU  -  Jahir Hussain AP
AU  -  Aravindan N.
PY  - 2026
JO  - Clin Transl Med
DO  - 10.1002/ctm2.70763
UR  - https://doi.org/10.1002/ctm2.70763
ER  - 

APA

S, M., P, S., S, A., MO, R., S, A., AP, J. H., & N., A. (2026). Precision post-translational modification of PML defines neuroblastoma clinical behaviour.. Clin Transl Med. https://doi.org/10.1002/ctm2.70763

Source records